94 related articles for article (PubMed ID: 35401923)
1. Clinicopathological role of Cyclin A2 in uterine corpus endometrial carcinoma: Integration of tissue microarrays and ScRNA-Seq.
Mo WJ; Liang ZQ; Huang JZ; Huang ZG; Zhi ZF; Chen JH; Chen G; Zeng JJ; Feng ZB
Int J Biol Markers; 2024 Jun; 39(2):168-183. PubMed ID: 38646803
[TBL] [Abstract][Full Text] [Related]
2. Hsa_Circ_0104206 is An Oncogenic circRNA in Colon Cancer by Targeting Mir-188-3p/CCNA2 Axis.
Li Z; Li Q; Chen Z
Horm Metab Res; 2023 Jul; 55(7):498-505. PubMed ID: 37276868
[TBL] [Abstract][Full Text] [Related]
3. ECPPF (E2F1, CCNA2, POLE, PPP2R1A, FBXW7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancer.
Gonzalez-Bosquet J; Weroha SJ; Bakkum-Gamez JN; Weaver AL; McGree ME; Dowdy SC; Famuyide AO; Kipp BR; Halling KC; Yadav S; Couch FJ; Podratz KC
PLoS One; 2022; 17(12):e0278408. PubMed ID: 36454788
[TBL] [Abstract][Full Text] [Related]
4. Identification of Key Prognostic Genes of Triple Negative Breast Cancer by LASSO-Based Machine Learning and Bioinformatics Analysis.
Chen DL; Cai JH; Wang CCN
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627287
[TBL] [Abstract][Full Text] [Related]
5. MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level.
Liu Y; Qi L; Ye B; Wang A; Lu J; Qu L; Luo P; Wang L; Jiang A
Cancer Biol Ther; 2024 Dec; 25(1):2345977. PubMed ID: 38659199
[TBL] [Abstract][Full Text] [Related]
6. CDK1 and CCNA2 play important roles in oral squamous cell carcinoma.
Zhang J; Di Y; Zhang B; Li T; Li D; Zhang H
Medicine (Baltimore); 2024 Apr; 103(16):e37831. PubMed ID: 38640322
[TBL] [Abstract][Full Text] [Related]
7. CCNA2 and NEK2 regulate glioblastoma progression by targeting the cell cycle.
Zhou HY; Wang YC; Wang T; Wu W; Cao YY; Zhang BC; Wang MD; Mao P
Oncol Lett; 2024 May; 27(5):206. PubMed ID: 38516683
[TBL] [Abstract][Full Text] [Related]
8. Key candidate genes and pathways in T lymphoblastic leukemia/lymphoma identified by bioinformatics and serological analyses.
Ren Y; Liang H; Huang Y; Miao Y; Li R; Qiang J; Wu L; Qi J; Li Y; Xia Y; Huang L; Wang S; Kong X; Zhou Y; Zhang Q; Zhu G
Front Immunol; 2024; 15():1341255. PubMed ID: 38464517
[TBL] [Abstract][Full Text] [Related]
9. Identifying molecular subtypes and tumor microenvironment infiltration signatures in kidney renal clear cell carcinoma based on stemness-associated disulfidptosis genes by integrating machine learning, single-cell analyses and experimental validation.
Liu H; Liang X; Tang G; Wang X; Wang Z; Tong L; Mao Q; Ma J; Wu J
Heliyon; 2024 Feb; 10(4):e26094. PubMed ID: 38390172
[TBL] [Abstract][Full Text] [Related]
10. Systems biology approach to identify biomarkers and therapeutic targets for colorectal cancer.
Sadat Kalaki N; Ahmadzadeh M; Najafi M; Mobasheri M; Ajdarkosh H; Karbalaie Niya MH
Biochem Biophys Rep; 2024 Mar; 37():101633. PubMed ID: 38283191
[TBL] [Abstract][Full Text] [Related]
11. Identification of key genes and pathways in adrenocortical carcinoma: evidence from bioinformatic analysis.
Yin M; Wang Y; Ren X; Han M; Li S; Liang R; Wang G; Gang X
Front Endocrinol (Lausanne); 2023; 14():1250033. PubMed ID: 38053725
[TBL] [Abstract][Full Text] [Related]
12. Gene dysregulation in acute HIV-1 infection - early transcriptomic analysis reveals the crucial biological functions affected.
Parker E; Judge MA; Pastor L; Fuente-Soro L; Jairoce C; Carter KW; Anderson D; Mandomando I; Clifford HD; Naniche D; Le Souëf PN
Front Cell Infect Microbiol; 2023; 13():1074847. PubMed ID: 37077524
[TBL] [Abstract][Full Text] [Related]
13. Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell Carcinoma.
Jiang A; Ye J; Zhou Y; Zhu B; Lu J; Ge S; Qu L; Xiao J; Wang L; Cai C
Cells; 2023 Jan; 12(3):. PubMed ID: 36766692
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma.
Zhang ZC; Liu YF; Xi P; Nie YC; Sun T; Gong BB
Hereditas; 2023 Jan; 160(1):1. PubMed ID: 36635779
[TBL] [Abstract][Full Text] [Related]
15. A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma.
Jiang A; Luo P; Chen M; Fang Y; Liu B; Wu Z; Qu L; Wang A; Wang L; Cai C
Cell Biosci; 2022 Dec; 12(1):209. PubMed ID: 36581992
[TBL] [Abstract][Full Text] [Related]
16. The potential mechanism of Neu5Gc inducing colorectal cancer based on network pharmacology and experimental validation.
Zhang LC; Liu YN; La XQ; Yan SN; Chen Y; Liang JY; Li ZY
Naunyn Schmiedebergs Arch Pharmacol; 2023 Apr; 396(4):705-718. PubMed ID: 36456746
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel histone phosphorylation prognostic signature in hepatocellular carcinoma based on bulk and single-cell RNA sequencing.
Fan L; Xu L; Tian S; Zheng X
Front Endocrinol (Lausanne); 2022; 13():965445. PubMed ID: 36120466
[TBL] [Abstract][Full Text] [Related]
18. Exploring the role of Xingren on COVID-19 based on network pharmacology and molecular docking.
Wang M; Yu B; Wang J; Wang Y; Liang L
J Food Biochem; 2022 Oct; 46(10):e14363. PubMed ID: 35933696
[TBL] [Abstract][Full Text] [Related]
19. CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types.
Jiang A; Zhou Y; Gong W; Pan X; Gan X; Wu Z; Liu B; Qu L; Wang L
Oxid Med Cell Longev; 2022; 2022():5910575. PubMed ID: 35401923
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
